This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elsevier Offers Free Access To ScienceDirect To Early Career Researchers Impacted By An Uncertain Job Market

AMSTERDAM, November 13, 2012 /PRNewswire/ --

- A new program aims to help postdocs stay current in their field

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of the Postdoc Free Access Program, a new initiative designed to help early career researchers who are in between research positions stay up-to-date in their field.

For scholars who have recently received their PhD and currently do not have a research position, the program will offer postdocs a Free Access Passport, with complimentary access to journals and books on ScienceDirect for up to 6 months.

The global economic climate for science funding has created new challenges for post doctoral students, especially for those looking for employment. In response to this growing trend, the program was conceived by editors and publishers at Elsevier who began to hear from postdocs in countries where funding has been hit hardest. Many emphasized the mounting pressure to stay competitive and publish, in many cases without the resources to do so.

Lenka Stockova, a research assistant from the Czech Republic said about the initiative, "This is a great opportunity for postdocs to keep in touch with the latest news in their field of interest and to identify the most active centers of research where they can apply for a position." According to Lenka, access to published research is "not only important, it is really necessary. Otherwise you cannot keep up with the latest research in your branch of study."

Professor Stephen Neidle, Editor-in-Chief of Bioorganic & Medicinal Chemistry, part of Elsevier's flagship Tetrahedron chemistry journal portfolio, who was part of the team that devised the program, explains, "Postdocs are facing a challenging time as big pharma has closed down many operations in Europe and the United States. University budgets are squeezed and research budgets are reduced. It will be important to keep the interest and commitment of the younger generation."

In order to qualify for the Free Access Passport, candidates will be asked to fill out a form verifying their credentials, before December 15, 2012. Once approved, they will receive a personal code allowing access to ScienceDirect.

Qualifying criteria include:
  • Postdoc researchers who have received their PhD within the past 10 years
  • At least one recent postdoc position which was completed in the past three months or that will be completed within three months
  • A letter of recommendation from the postdoc's supervisor and/or institution verifying employment

For Alicia Wise, Elsevier's Director of Universal Access, the program provides an opportunity to invest in the future of science by keeping promising young scientists--who would otherwise be without access to content--current in their field. "Postdocs today face a multitude of challenges, between an uncertain job market and the inherent temporary nature of research projects themselves," she said. "At Elsevier, we know that access to published research is vital for early career researchers to stay connected, to stay competitive, and to get that next project or job."

More information about the program and the application form can be accessed at http://www.elsevier.com/postdocfreeaccess

About ScienceDirect

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.12 +5.48 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs